Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

Tanta University191 enrolled

Overview

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19. As, zinc may be of value in these cases and may be of value in enhancing chloroquine effect.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

191

Conditions

COVID

Interventions

Chloroquine or hydroxychloroquineDRUG

Chloroquine or hydroxychloroquine

zincDRUG

Zinc tablets

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with positive COVID-19. Exclusion Criteria: * Contraindications or hypersensitivity to chloroquine.

Locations (1)

Tanta university hospital, Assuit University, Ainshams University

Tanta, Egypt

Outcomes

Primary Outcomes

Number of patients with improvement or mortality

The number of patients with improvement or mortality.

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.